NanoViricides
NNVC
#10132
Rank
ยฃ16.61 M
Marketcap
ยฃ0.92
Share price
0.82%
Change (1 day)
-19.31%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of June 2025 : ยฃ5.64 Million

According to NanoViricides's latest financial reports the company has ยฃ5.64 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$ยฃ9.06 M-22.49%
2023-06-30$ยฃ11.69 M-38.39%
2022-06-30$ยฃ18.98 M-12.25%
2021-06-30$ยฃ21.62 M23.16%
2020-06-30$ยฃ17.56 M110.31%
2019-06-30$ยฃ8.35 M-37.56%
2018-06-30$ยฃ13.37 M-14.41%
2017-06-30$ยฃ15.62 M-9.65%
2016-06-30$ยฃ17.29 M-14.66%
2015-06-30$ยฃ20.26 M48.35%
2014-06-30$ยฃ13.65 M159.28%
2013-06-30$ยฃ5.26 M-40.33%
2012-06-30$ยฃ8.82 M39.29%
2011-06-30$ยฃ6.33 M47.45%
2010-06-30$ยฃ4.29 M184.96%
2009-06-30$ยฃ1.5 M576.6%
2008-06-30$ยฃ0.22 M-10.8%
2007-06-30$ยฃ0.24 M-63.11%
2006-06-30$ยฃ0.67 M-1915.41%
2005-06-30$-ยฃ0.04 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
-ยฃ0.3 Billion-5,259.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-ยฃ0.12 Billion-2,184.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ16.10 B 285,311.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ13.96 B 247,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ38.96 B 690,375.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ15.89 B 281,586.77%๐Ÿ‡ฌ๐Ÿ‡ง UK